Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 5 of 160 for:    Idiopathic Dilated Cardiomyopathy

Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00466713
Recruitment Status : Terminated (concern over safety of rosiglitazone in heart failure)
First Posted : April 27, 2007
Last Update Posted : May 13, 2014
Sponsor:
Information provided by (Responsible Party):
Michael Fowler, Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2007
Actual Study Completion Date : December 2007